表紙
市場調査レポート

VivaCell Biotechnology Espana S.L.:製品パイプライン分析

VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 320001
出版日 ページ情報 英文 26 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
VivaCell Biotechnology Espana S.L.:製品パイプライン分析 VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015
出版日: 2015年12月16日 ページ情報: 英文 26 Pages
概要

VivaCell Biotechnology Espana S.L. は神経変性疾患や慢性的炎症性疾患治療のためのファイトカノビノイド誘導体の開発に特化したバイオ製薬会社です。同社はまた製薬会社を始め、食品、化粧品会社に委託研究組織サービスを提供しています。

当レポートでは、VivaCell Biotechnology Espana S.L.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

VivaCell Biotechnology Espana S.L.の基本情報

  • VivaCell Biotechnology Espana S.L.の概要
  • 主要情報
  • 企業情報

VivaCell Biotechnology Espana S.L.:R&Dの概要

  • 主な治療範囲

VivaCell Biotechnology Espana S.L.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

VivaCell Biotechnology Espana S.L.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

VivaCell Biotechnology Espana S.L.:薬剤プロファイル

  • CDE-001
  • VCE-003
  • VCE-0032
  • VCE-0048

VivaCell Biotechnology Espana S.L.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

VivaCell Biotechnology Espana S.L.:最近のパイプライン動向

VivaCell Biotechnology Espana S.L.:休止中のプロジェクト

VivaCell Biotechnology Espana S.L.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07876CDB

Summary

Global Markets Direct's, 'VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015', provides an overview of the VivaCell Biotechnology Espana S.L.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VivaCell Biotechnology Espana S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of VivaCell Biotechnology Espana S.L. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of VivaCell Biotechnology Espana S.L.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the VivaCell Biotechnology Espana S.L.'s pipeline products

Reasons to buy

  • Evaluate VivaCell Biotechnology Espana S.L.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of VivaCell Biotechnology Espana S.L. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the VivaCell Biotechnology Espana S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of VivaCell Biotechnology Espana S.L. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of VivaCell Biotechnology Espana S.L.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of VivaCell Biotechnology Espana S.L. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • VivaCell Biotechnology Espana S.L. Snapshot
    • VivaCell Biotechnology Espana S.L. Overview
    • Key Information
    • Key Facts
  • VivaCell Biotechnology Espana S.L. - Research and Development Overview
    • Key Therapeutic Areas
  • VivaCell Biotechnology Espana S.L. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • VivaCell Biotechnology Espana S.L. - Pipeline Products Glance
    • VivaCell Biotechnology Espana S.L. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • VivaCell Biotechnology Espana S.L. - Drug Profiles
    • CDE-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-0032
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCE-0048
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • VivaCell Biotechnology Espana S.L. - Pipeline Analysis
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Target
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Route of Administration
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Molecule Type
    • VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action
  • VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates
  • VivaCell Biotechnology Espana S.L. - Dormant Projects
  • VivaCell Biotechnology Espana S.L. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • VivaCell Biotechnology Espana S.L., Key Information
  • VivaCell Biotechnology Espana S.L., Key Facts
  • VivaCell Biotechnology Espana S.L. - Pipeline by Indication, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Stage of Development, 2015
  • VivaCell Biotechnology Espana S.L. - Monotherapy Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products/ Combination Treatment Modalities, 2015
  • VivaCell Biotechnology Espana S.L. - Preclinical, 2015
  • VivaCell Biotechnology Espana S.L. - Discovery, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Target, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Route of Administration, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Molecule Type, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action, 2015
  • VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates, 2015
  • VivaCell Biotechnology Espana S.L. - Dormant Developmental Projects,2015

List of Figures

  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Indication, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Stage of Development, 2015
  • VivaCell Biotechnology Espana S.L. - Monotherapy Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Partnered Products in Pipeline, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Target, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Route of Administration, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline by Top 10 Molecule Type, 2015
  • VivaCell Biotechnology Espana S.L. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top